OverviewTirzepatide is a dual GIP/GLP-1 receptor agonist used in laboratory metabolic signaling studies. Research FocusIt is employed to investigate incretin-mediated receptor interactions and glucose-regulating biochemical pathways. Mechanism of InterestThe dual agonism supports controlled studies of receptor synergy and downstream intracellular signaling mechanisms. Compliance NoticeFor research only. Not for human consumption